Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-09-23

Clinical Trial Update: Safety and Efficacy of Dose Conversion From Vicodin® to Buprenorphine Transdermal System (Butrans™) in Subjects With OA Pain [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of converting patients with osteoarthritis from hydrocodone/acetaminophen (Vicodin) to the buprenorphine transderma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUTRANS (Buprenorphine)
  • Vicodin (hydrocodone/acetaminophen)

Snippet

Sponsor: Purdue Pharma LP | Conditions: Osteoarthritis | Phase 3 | Status: COMPLETED | Results posted: 2010-09-23